bonafton

Known as: 6-bromo-1,2-naphthoquinone 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1975-2004
012319752004

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1991
1991
The immunocorrective activity of bonaphthon, an antiviral agent, was studied in 27 patients with chronic diseases of the buccal… (More)
Is this relevant?
1988
1988
It was shown for the first time that the antiviral drug bonafton administered orally to nonlinear albino mice in single doses of… (More)
Is this relevant?
1987
1987
Administration of an antiviral agent bonafton (1.5 mg/kg, intraperitoneally) for 5 days to mice immunized with a supraoptimal… (More)
Is this relevant?
1985
1985
Study of the primary immune response in CBA mice which were injected with bonafton (1.5-3 mg/kg i.p.) for 3 days has revealed… (More)
Is this relevant?
Review
1980
Review
1980
The ability of 14C-bonafton to penetrate the placental bar was studied in female Wistar rats. The drug was shown to penetrate… (More)
Is this relevant?
1980
1980
The first generation progeny of rats received days 10-13 of pregnancy a new antiviral drug bonaphthon (400 mg/kg) which exerts a… (More)
Is this relevant?
1980
1980
The toxicity of the original drug bonaphthon was studied in pregnant and nonpregnant mice and rats given the drug orally and… (More)
Is this relevant?
1979
1979
The parameters of bonafton pharmacokinetics (absorption, distribution, excretion) have been studied in male Wistar rats at single… (More)
Is this relevant?
1976
1976
The therapeutic effectiveness of bonaphthone and rimantadine was studied by treatment of 439 patients with influenza between 18… (More)
Is this relevant?
1975
1975
Bonaphthone (6-naphthoquinone-1,2) administered per os produces a prounced therapeutic effect in experimental herpetic keratitis… (More)
Is this relevant?